TECH vs REGN: Which Stock is Better?
Side-by-side comparison of Bio-Techne Corp and Regeneron Pharmaceuticals Inc in 2026
TECH
Bio-Techne Corp
—
REGN
Regeneron Pharmaceuticals Inc
$672.15
Key Metrics Comparison
| Metric | TECH | REGN | Winner |
|---|---|---|---|
| Market Cap | $8.49B | $59.10B | REGN |
| P/E Ratio | 65.23 | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TECH
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TECH or REGN a better investment?
Comparing TECH and REGN: Bio-Techne Corp has a market cap of $8.49B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TECH and REGN?
TECH (Bio-Techne Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TECH or REGN?
Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 65.2x).
Which is growing faster: TECH or REGN?
Both TECH and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TECH or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TECH or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $8.49B for TECH.
Should I buy TECH or REGN in 2026?
Both TECH and REGN have investment merit. TECH trades at $N/A while REGN trades at $672.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TECH and REGN stock?
Key differences: Market Cap ($8.49B vs $59.10B), P/E Ratio (65.2x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TECH or REGN in 2026?
The choice between TECH and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TECH and REGN?
TECH (Bio-Techne Corp) has a market cap of $8.49B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.